• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEOTRACT, INC. NEOTRACT UROLIFT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEOTRACT, INC. NEOTRACT UROLIFT SYSTEM Back to Search Results
Model Number UROLIFT SYSTEM
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Urinary Retention (2119); Urinary Tract Infection (2120); Dysuria (2684)
Event Date 05/29/2022
Event Type  Injury  
Event Description
The patient received a prostatic urethral lift (pul) on (b)(6) 2022 with the subject device.The physician noted during cystoscopy performed on (b)(6) 2022, that the cystoscopy results weren¿t ¿awful¿ and the patient was able to void 233 cc with a residual volume of 227 cc.On (b)(6) 2022 and (b)(6) 2022, additional details were provided by the physician and the patient¿s wife, respectively, as follows.On the evening of the procedure, the patient presented to the ed for retention and required a foley catheter be placed.On (b)(6) 2022, the catheter was removed and the patient passed a voiding trial.On (b)(6) 2022, the patient returned to the ed where a new catheter was placed and he was treated with antibiotics for a uti.The patient reported on (b)(6) 2022 he was seen in the office for follow up and had his catheter removed and passed a void trial.On (b)(6) 2022, the patient returned to the physician and was taught how to self-catheterize.Later that same day, the patient reportedly voided a portion of an implant at home.On (b)(6) 2022, the patient was diagnosed with another uti and treated with antibiotics.The patient reportedly returned to the ed on (b)(6) 2022 and (b)(6) 2022 for inability to urinate and difficulty in placing the catheter was reported.On (b)(6) 2022, the catheter was removed and urodynamic testing showed ¿adequate bladder function¿.On (b)(6) 2022, the patient presented to his urologist¿s office for urinary retention and a catheter was placed without incident.On (b)(6) 2022, the patient presented to the ed again for retention.On (b)(6) 2022, the patient had his catheter removed by his urologist during an office visit.That same day, he developed increasing pain with urination and called his primary care physician who prescribed antibiotics.Currently, patient reports no catherization, slow stream and continued dysuria and is seeking continuing care.No further information is available at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEOTRACT UROLIFT SYSTEM
Type of Device
UROLIFT SYSTEM
Manufacturer (Section D)
NEOTRACT, INC.
4155 hopyard road
pleasanton CA 94588
Manufacturer (Section G)
NEOTRACT, INC.
4155 hopyard road
pleasanton CA 94588
Manufacturer Contact
brian gall
4155 hopyard rd
pleasanton, CA 94588
9253296547
MDR Report Key15204647
MDR Text Key297670977
Report Number3015181082-2022-00018
Device Sequence Number1
Product Code PEW
UDI-Device Identifier10814932020213
UDI-Public10814932020213
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K193269
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 08/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/10/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUROLIFT SYSTEM
Device Catalogue NumberIPN919209
Device Lot Number73L2101012
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/14/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient SexMale
-
-